Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc. financial statements

Werewolf Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 60.82M10-K
Cash and equivalentsUSD 57.05M10-Q
Total debtUSD 32.09M10-K

Werewolf Therapeutics, Inc. financials on 6ix · Werewolf Therapeutics, Inc. on 6ix